母亲接触血管紧张素 II 受体阻滞剂后妊娠的过程及结局——病例报告与文献综述 - Suppr | 超能文献

Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.

作者信息

Enzensberger C, Eskef K, Schwarze A, Faas D, Axt-Fliedner R

出版信息

Ultraschall Med. 2012 Oct;33(5):493-6. doi: 10.1055/s-0029-1245942. Epub 2011 May 31.

DOI:10.1055/s-0029-1245942

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.母亲接触血管紧张素 II 受体阻滞剂后妊娠的过程及结局——病例报告与文献综述

Ultraschall Med. 2012 Oct;33(5):493-6. doi: 10.1055/s-0029-1245942. Epub 2011 May 31.

2

Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker.由于母亲接触血管紧张素受体阻滞剂导致的可逆性急性胎儿肾衰竭。

Pediatr Nephrol. 2008 Feb;23(2):333-4. doi: 10.1007/s00467-007-0618-8. Epub 2007 Sep 26.

3

Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients.奥美沙坦的安全性和疗效：一项对 156682 例高血压患者的观察性汇总分析。

Expert Opin Drug Saf. 2011 Mar;10(2):185-96. doi: 10.1517/14740338.2011.552426. Epub 2011 Jan 23.

4

[Clinical profiles of new angiotensin II receptor blockers: telmisartan, olmesartan medoxomil, and irbesartan].新型血管紧张素II受体阻滞剂的临床概况：替米沙坦、奥美沙坦酯和厄贝沙坦

Nihon Rinsho. 2004 Jan;62(1):193-202.

5

[Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].[血管紧张素 II 受体抑制剂的胎儿毒性。病例报告]

Gynecol Obstet Fertil. 2007 Jun;35(6):556-60. doi: 10.1016/j.gyobfe.2007.03.015. Epub 2007 Jun 1.

6

Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil.拮抗血管紧张素II 1型受体：聚焦于奥美沙坦酯。

Clin Ther. 2004;26 Suppl A:A12-20. doi: 10.1016/s0149-2918(04)90141-5.

7

Two amlodipine/ARB combinations for hypertension.两种氨氯地平/血管紧张素受体阻滞剂联合用药治疗高血压

Med Lett Drugs Ther. 2007 Dec 17;49(1276):101-2.

8

[In diarrhea of unknown origin also think of olmesartan!].[对于不明原因的腹泻也要考虑奥美沙坦！]

MMW Fortschr Med. 2015 Mar 5;157(4):34. doi: 10.1007/s15006-015-2764-4.

9

Renin-angiotensin-aldosterone system blockade is safe and effective in elderly hypertensive patients with and without impaired renal function.肾素-血管紧张素-醛固酮系统阻断剂对于伴有或不伴有肾功能损害的老年高血压患者而言是安全且有效的。

High Blood Press Cardiovasc Prev. 2012 Dec;19(4):197-8. doi: 10.1007/BF03297629.

10

Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).奥美沙坦与钙拮抗剂随机对照（OSCAR）研究的原理、设计及患者基线特征：一项比较日本老年高危高血压患者中高剂量血管紧张素II受体阻滞剂（ARB）单药治疗与ARB联合钙通道阻滞剂治疗心血管事件发生率的研究（ClinicalTrials.gov编号：NCT00134160）

Hypertens Res. 2009 Jul;32(7):575-80. doi: 10.1038/hr.2009.60. Epub 2009 May 15.

引用本文的文献

1

Methylation-induced suppression of BEX1 activates AKT/ERK/STAT3 signaling pathways regulating cell cycle and apoptosis in glioma.甲基化诱导的BEX1抑制激活调节胶质瘤细胞周期和凋亡的AKT/ERK/STAT3信号通路。

Sci Rep. 2025 Aug 13;15(1):29716. doi: 10.1038/s41598-025-14123-8.